Stay connected.
ACGT delivers two monthly newsletters straight to your email inbox, highlighting ACGT events, funding opportunities, achievements and the latest progress in the development of cancer cell and gene therapies.
The ACGT Monthly E-Newsletter keeps you updated on what we are doing to advance the goal of a cancer-free future, while our Research Roundup is the go-to source for scientific progress in the field, grant opportunities, and publications by our Research Fellows.
Subscribe today to ensure you are part of Alliance for Cancer Gene Therapy.
ACGT Blog
-
January 2026 ACGT Research News Roundup.
In this month’s ACGT Research News Roundup, we’re covering new publications in cell and gene therapy research, exciting developments in the clinic and biotech, and highlighting research from our ACGT Scientific Advisory Council (SAC) and Research Fellows. Cancer Cell and Gene Therapy Industry News T cell researchers receive the Nobel Prize in Physiology or Medicine…
-
ACGT hosts lunch symposium, SAC members honored at SITC 2025.
ACGT Scientific Advisory Council member Carl June, MD, (University of Pennsylvania) and ACGT Board of Directors member Marc Engelsgjerd, MD (Royalty Pharma) speak to assembled experts and guests at ACGT’s Lunch Symposium at SITC 2025. Alliance for Cancer Gene Therapy (ACGT) had a strong presence at this year’s Society for Immunotherapy of Cancer (SITC) 2025…
-
19th annual Swim Across America – Fairfield County open water swim raises more than $400K for ACGT.
Close to 230 swimmers hit the water on June 21 in Stamford, Conn, for the annual Swim Across America – Fairfield County (SAA-FC) open water swim, which benefited Alliance for Cancer Gene Therapy (ACGT) for the 19th consecutive year. If you ask the organizers and the participants, the day couldn’t have gone any better. A streak…
Recent Press Releases
-
Alliance for Cancer Gene Therapy Adds Jonathan S. Doctor and John Neamonitis to Board of Directors
Both Doctor and Neamonitis have extensive experience building and guiding successful enterprises. STAMFORD, Conn., [June 16, 2026] — Alliance for Cancer Gene Therapy (ACGT) is proud to welcomes Jonathan S. Doctor, MBA, MPH, of Ambler Brook, and John Neamonitis, of Lakehouse Ventures, to the foundation’s Board of Directors. Together, they bring deep experience in healthcare operations, investment,…
-
Alliance for Cancer Gene Therapy Adds Two New Members to Scientific Advisory Council.
Drs. Singh and Gottschalk are leading cell and gene therapy researchers at world-class cancer centers. STAMFORD, Conn., January 14, 2026 — Alliance for Cancer Gene Therapy (ACGT) welcomes Sheila Singh, MD, PhD (King’s College London), and Stephen Gottschalk, MD (St. Jude Children’s Research Hospital), to its 22-person Scientific Advisory Council, which includes the most accomplished and innovative thought…
-
Alliance for Cancer Gene Therapy Awards Research Grant to In Vivo CRISPR Screen for Pancreatic Cancer.
Marcela Maus, MD, PhD, Massachusetts General Hospital receives three-year research grant from ACGT. STAMFORD, Conn., Oct. 29, 2025 — A $500,000 grant from Alliance for Cancer Gene Therapy (ACGT) will support Massachusetts General Hospital scientists who are probing the use of in vivo CRISPR screening to improve CAR T cell therapy in pancreatic cancer. The grant was awarded to Marcela Maus,…